During the past decade, Royal Marsden NHS Foundation Trust conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Marsden NHS Foundation Trust" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 2 trials, followed by "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Royal Marsden NHS Foundation Trust" with 1 trials sponsored and "University of Oxford" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Marsden NHS Foundation Trust" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "GORTEC (Head and Neck Oncology and Radiotherapy Group)" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Royal Marsden NHS Foundation Trust" are "Advanced Malignant Pleural Mesothelioma" (1 trials), "Bladder Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Dedifferentiated Liposarcoma" (1 trials) and "MSS" (1 trials). Many other conditions were trialed in "Royal Marsden NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "Royal Marsden NHS Foundation Trust" are "Drug" (6 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "CVA21/pembrolizumab" (1 trials), "Cabazitaxel" (1 trials), "Cisplatin" (1 trials) and "Ifosfamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Marsden NHS Foundation Trust" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Royal Marsden NHS Foundation Trust". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Royal Marsden NHS Foundation Trust, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Marsden NHS Foundation Trust, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".